Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PEPD | P12955 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.32 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18532463 | 0.87 | PEPD (0.42) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL7734513 | 0.87 | PEPD (0.42) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL195046 | 0.87 | PEPD (0.42) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL4766405 | 0.87 | PEPD (0.42) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL14529590 | 0.87 | MEN1 (0.39) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL11405911 | 0.86 | HSD11B1 (0.33) | HSD11B1HSD11B2 | |
| SCHEMBL7768150 | 0.85 | PEPD (0.41) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL9419364 | 0.85 | MEN1 (0.42) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL55536 | 0.85 | PEPD (0.41) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL7598028 | 0.85 | PEPD (0.41) | PEPDMEN1BLMKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118339274-A | Brandy replica | 艾娃食品实验室股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| EP-3921327-A1 | GLYCYRRHETINIC ACID DERIVATIVES FOR USE IN TREATING HYPERKALEMIA | Ardelyx, Inc. (US) | 2021-12-15 | — | — | EP | disclosed |
| WO-2020163642-A1 | GLYCYRRHETINIC ACID DERIVATIVES FOR USE IN TREATING HYPERKALEMIA | ARDELYX, INC. (US) | 2020-08-13 | — | — | WO | disclosed |